0001209191-20-047804.txt : 20200820
0001209191-20-047804.hdr.sgml : 20200820
20200820183655
ACCESSION NUMBER: 0001209191-20-047804
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200818
FILED AS OF DATE: 20200820
DATE AS OF CHANGE: 20200820
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Erbez Georgia
CENTRAL INDEX KEY: 0001557930
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38800
FILM NUMBER: 201121104
MAIL ADDRESS:
STREET 1: 6300 DUMBARTON CIRCLE
CITY: FREMONT
STATE: CA
ZIP: 94555
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Harpoon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001708493
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 473458693
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 131 OYSTER POINT BOULEVARD
STREET 2: SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-443-7400
MAIL ADDRESS:
STREET 1: 131 OYSTER POINT BOULEVARD
STREET 2: SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-08-18
0
0001708493
Harpoon Therapeutics, Inc.
HARP
0001557930
Erbez Georgia
C/O HARPOON THERAPEUTICS, INC.
131 OYSTER POINT BOULEVARD, SUITE 300
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Financial Officer
Common Stock
2020-08-18
4
P
0
2098
11.60
A
3915
I
See footnote
Common Stock
2020-08-19
4
P
0
5000
11.40
A
8915
I
See footnote
Common Stock
47292
D
Common Stock
6700
I
See footnote
Shares indirectly held by Georgia Leigh Erbez Charles Schwab & Co Inc Cust IRA Contributory ("Georgia Erbez IRA Contributory"). The Reporting Person has beneficial ownership over these shares held by Georgia Erbez IRA Contributory.
Shares indirectly held by David Milan Erbez Charles Schwab & Co Inc Cust IRA Contributory ("David Erbez IRA Contributory"). The Reporting Person has beneficial ownership over these shares held by David Erbez IRA Contributory.
/s/ Georgia Erbez by Christopher Whitmore, Attorney-in-Fact
2020-08-20